CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Open-market sale Chief Medical Officer sold 20,414 shares at an average $59.53 ($1,215,344)
- 4 Open-market sale SVP, Technical Operations sold 32,882 shares at an average $63.76 ($2,096,419)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $60.29 ($452,206)
- 4 Open-market sale President and CEO sold 20,000 shares at an average $63.11 ($1,262,261)
- 4 Open-market sale SVP, General Counsel sold 15,000 shares at $72.06 ($1,080,900)
- 4 Open-market sale Chief Medical Officer sold 20,414 shares at an average $68.28 ($1,393,933)
- 4 Open-market sale President and CEO sold 20,000 shares at an average $68.25 ($1,364,902)
- 4 Open-market sale Chief Financial Officer sold 73,418 shares at an average $70.20 ($5,154,020)
- 4 Open-market sale Chief Medical Officer sold 20,414 shares at an average $62.37 ($1,273,212)
- 4 Open-market sale SVP, General Counsel sold 5,000 shares at an average $61.78 ($308,890)
- 4 Open-market sale SVP, Technical Operations sold 62,309 shares at $60.85 ($3,791,503)
- 4 Open-market sale Chief Medical Officer sold 20,414 shares at an average $60.28 ($1,230,541)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $59.37 ($445,275)
- 4 Open-market sale President and CEO sold 7,510 shares at an average $59.35 ($445,745)
- 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $63.80 ($1,275,914)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $74.86 ($561,472)
- 4 Open-market sale President and CEO sold 7,510 shares at an average $74.91 ($562,564)
- 4 Open-market sale President and CEO sold 7,510 shares at an average $66.46 ($499,118)
- 4 Open-market sale SVP, General Counsel sold 5,000 shares at an average $65.96 ($329,806)
- 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $65.43 ($490,710)
Page 14 of 22 · 435 filings